Literature DB >> 26239205

Ophthalmic manifestations and outcomes after cavernous sinus thrombosis in children.

Garett S Frank1, Jesse M Smith1, Brett W Davies2, David M Mirsky3, Eric M Hink1, Vikram D Durairaj4.   

Abstract

PURPOSE: To review the causes, treatment, and outcomes of cavernous sinus thrombosis (CST) in children.
METHODS: The medical records of children (<18 years of age) diagnosed with thrombophlebitis of an intracranial venous sinus were reviewed to identify cases of CST presenting to Children's Hospital Colorado from January 2000 through January 2013. Cases were evaluated for etiology, symptoms, imaging characteristics, treatment, and outcomes.
RESULTS: A total of 110 children with a venous thrombus of an intracranial sinus were included. Of these, 9 had a CST. All cases were confirmed by magnetic resonance imaging. All 9 had sinusitis, 4 had orbital involvement, and 1 resulted from a nasal septal abscess. Eight cases presented with ophthalmoplegia, and 5 presented with decreased vision. Every patient underwent sinus surgery: 4 underwent orbitotomy for abscess drainage, and 1 required bilateral exenteration. Cultures were inconclusive in 2 cases, and 2 cases were culture positive rhino-orbital mucormycosis. There was 1 case of methicillin-resistant Staphylococcus aureus. Of the 9 cases, 4 returned to normal vision and ocular motility; 5 had permanent ophthalmoplegia and vision loss. There were no cases of mortality.
CONCLUSIONS: CST is a rare complication of orbital and sinus disease. High clinical suspicion, early neurologic imaging, and a multidisciplinary approach to management are key factors in reducing morbidity and mortality from CST in children.
Copyright © 2015 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26239205     DOI: 10.1016/j.jaapos.2015.06.001

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  8 in total

Review 1.  Neurological Complications of Acute and Chronic Sinusitis.

Authors:  Andrea Ziegler; Monica Patadia; James Stankiewicz
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-05       Impact factor: 5.081

2.  Lateral rectus atrophy in cavernous sinus thrombosis.

Authors:  Bertie Geng; Xiao Wu; Ajay Malhotra
Journal:  Clin Neuroradiol       Date:  2018-10-19       Impact factor: 3.649

3.  Pediatric cavernous sinus and superior ophthalmic vein thrombophlebitis complicated by peri-venous orbital abscesses.

Authors:  Kayla Swiatek; Eric Peterson; Lalita Gupta; Peter Timoney
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-29

4.  Orbital apex syndrome secondary to a fungal nasal septal abscess caused by Scedosporium apiospermum in a patient with uncontrolled diabetes: a case report.

Authors:  Ippei Kishimoto; Shogo Shinohara; Tetsuhiro Ueda; Shoichi Tani; Hajime Yoshimura; Yukihiro Imai
Journal:  BMC Infect Dis       Date:  2017-09-26       Impact factor: 3.090

5.  Multidisciplinary Management of COVID-Associated Mucormycosis Syndemic in India.

Authors:  Rupa Mehta; Nitin M Nagarkar; Atul Jindal; Karthik Nagaraja Rao; S B Nidhin; Ripu Daman Arora; Anil Sharma; Archana Wankhede; Satish Satpute; Sharmistha Chakravarty; N K Agrawal; Pankaj Kannauje; Ajoy Behera; Pugazhenthan Thangaraju
Journal:  Indian J Surg       Date:  2021-10-06       Impact factor: 0.437

6.  Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis.

Authors:  Ruchi Goel; Ritu Arora; Shalin Shah; Mohit Chhabra; Jyoti Kumar; Nita Khurana; Swati Gupta; Samreen Khanam; Sumit Kumar; Sonam Singh; Ravi Meher; Meenakshi Thakar; Anju Garg
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2022-05-11       Impact factor: 2.011

7.  MR imaging of cavernous sinus thrombosis.

Authors:  Harsimran Bhatia; Ravinder Kaur; Raveena Bedi
Journal:  Eur J Radiol Open       Date:  2020-03-03

8.  Cerebral Venous Thrombosis: A Critical Appraisal.

Authors:  Amos Lal; Andrew C F Hui
Journal:  Ann Indian Acad Neurol       Date:  2020-12-08       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.